This story was produced in partnership with DoubleBlind, an independent magazine covering the psychedelic industry. In the spring of 2022, a 49-year-old New Yorker named David* headed south to Cancún, Mexico. He went to overcome his dependency on drugs using ibogaine, the primary alkaloid in a central African root bark …
Read More »Science Versus Experience in Psychedelic Research
For the last five years, my lead chemist, Armando, has developed new products that people with advanced chemistry degrees have assured me are impossible to make. From putting powderized functional mushrooms into vegan softgels to creating squeeze dabs with different cannabinoids and variable melting points, my guy keeps proving the …
Read More »